SGMO: Sangamo Therapeutics, Inc. Stock

by  •  • Comments Off on SGMO: Sangamo Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 101.37
Enterprise Value ($M) 59.45
Book Value ($M) 22.77
Book Value / Share 0.10
Price / Book 4.45
NCAV ($M) -27.17
NCAV / Share -0.12
Price / NCAV -3.73

Profitability (mra)
Return on Invested Capital (ROIC) -1.84
Return on Assets (ROA) -0.76
Return on Equity (ROE) -1.73

Liquidity (mrq)
Quick Ratio 1.13
Current Ratio 1.13

Balance Sheet (mrq) ($M)
Current Assets 51.69
Assets 101.64
Liabilities 78.86
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 57.80
Operating Income -98.35
Net Income -97.94
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -67.14
Cash from Investing 37.52
Cash from Financing 28.38

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
4 days ago 13G/A Wasatch Advisors Inc 5.20 -16.88
11-12 13G/A Vanguard Group Inc 4.60 0.00
08-16 13G/A Biogen Inc. 1.60 -77.82
07-08 13G/A BlackRock, Inc. 2.30 -66.64

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-03-17 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K _______________________________________________________________________________________________ ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHAN
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-15 1,530,139 4,457,471 34.33
2025-05-14 2,174,174 5,421,731 40.10
2025-05-13 5,266,993 15,228,346 34.59
2025-05-12 781,423 3,480,615 22.45

(click for more detail)

Similar Companies
SAVA – Cassava Sciences, Inc. SBFM – Sunshine Biopharma, Inc.
SCLX – Scilex Holding Company SHPH – Shuttle Pharmaceuticals Holdings, Inc.
SILO – Silo Pharma, Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Sangamo BioSciences